Literature DB >> 11269564

Comparative safety of bone remodeling agents with a focus on osteoporosis therapies.

M Kleerekoper1, J R Schein.   

Abstract

This article reviews the different treatments currently available for osteoporosis and examines the benefits and adverse events that are associated with each. While emphasizing safety considerations, this review summarizes the following treatments for osteoporosis: calcium supplements, fluoride, hormone replacement therapy, raloxifene, bisphosphonates, salmon calcitonin, and calcitriol. Before prescribing any of these agents, the clinician should review the risk/benefit profile of each drug in the context of the individual patient's history, concomitant diseases, concurrent medications, and general physical condition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11269564     DOI: 10.1177/00912700122010050

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  2 in total

1.  Storage function of cartilage oligomeric matrix protein: the crystal structure of the coiled-coil domain in complex with vitamin D(3).

Authors:  Suat Ozbek; Jürgen Engel; Jörg Stetefeld
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

2.  Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates.

Authors:  Shonda A Foster; Kathleen A Foley; Eric S Meadows; Joseph A Johnston; Sara Wang; Gerhardt M Pohl; Stacey R Long
Journal:  BMC Womens Health       Date:  2008-12-23       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.